Lupus Science and Medicine (Dec 2022)
1116 Evidence in support of the hypothesis that bolstering Endothelial Cell Sphingosine 1- Phosphate Receptor 1 signaling is a rational approach for the treatment of lupus nephritis
Abstract
No abstracts available.